KRAS-IRF2 axis drives immune suppression and immune therapy resistance in colorectal cancer

Liao, Wenting, Overman, Michael J., Boutin, Adam T., Shang, Xiaoying, Zhao, Di, Dey, Prasenjit, Li, Jiexi, Wang, Guocan +19 more·2019·Cancer Cell

DOI 10.1016/j.ccell.2019.02.008

Cited by (619)

Items 501–600 of 619

Targeting KRAS and SHP2 signaling pathways for immunomodulation and improving treatment outcomes in solid tumors
Priyanka Sahu, Ankita Mitra, Anirban Ganguly · 2024 · International review of cytology
MicroRNAs Involved in Small-cell Lung Cancer as Possible Agents for Treatment and Identification of New Targets
Ulrich H. Weidle, Adam Nopora · 2021 · Cancer Genomics & Proteomics
Targeting tumor-associated neutrophils in immunotherapy
Sharif Rahmy, Xin Lü · 2021 · Elsevier eBooks
Case report: long-term sustained remission in a case of metastatic colon cancer with high microsatellite instability and KRAS exon 2 p.G12D mutation treated with fruquintinib after local radiotherapy: a case report and literature review
Ruiqi Wang, Dan Cong, Yuansong Bai, Wenlong Zhang · 2023 · Frontiers in Pharmacology
Clinical and molecular impacts of tumor mutational burden in histological and cytological specimens from cancer patients
Lin Li, Chuan Chen, Chaojun Liu, Li Na Niu, Chunguo Pan · 2022 · Annals of Translational Medicine
Tumor-induced endothelial RhoA activation mediates tumor cell transendothelial migration and metastasis
Md Sanaullah Sajib, Fatema Tuz Zahra, Μαργαρίτα Λάμπρου, Racheal Grace Akwii, Jee Hyun Park, Manuel Osorio, Paul Tullar, Colleen L. Doçi, Chonghe Zhang, Stephan Huveneers et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Association of G12D mutation in the KRAS gene with HPV and EBV in gastrointestinal cancer tissues
Vahideh Hamidi, Arefeh Ebrahimian Shiadeh, Alijan Tabarraei, Hadi Razavi Nikoo, Farzin Sadeghi, Ghodsieh Kamrani, Yousef Yahyapour, Abdolvahab Moradi · 2024 · Journal of International Medical Research
hmLIGHT Enhances Vaccine Antitumor Effects by Facilitating T-cell Infiltration and Activation in the 4T1 Breast Cancer Model
Ling Dong, Shiqi Zhang, Qimuge Wuri, Xueli Qu, Ke Zhang, Zongyu Cai, Yaru Qiao, Mengfan Feng, Chu Wang, Hui Wu et al. · 2025 · Molecular Cancer Therapeutics
Inflammation-Driven Tumorigenesis: Mechanisms, Immune Evasion, and Therapeutic Strategies
Vivek Kumar Singh, Mohmmad Kashif, Roma Pahwa, Anand Narayan Singh · 2025 · International Journal of Clinical and Translational Medicine
The critical role of homing in TIL therapy success: From biology to clinical application
Yousef Mohammadi, Hossein Khorramdelazad, Narjes Soleimanifar, Mohsen Badalzadeh, Mohammad Hossein Nicknam, Gholam Ali Kardar · 2025 · Critical Reviews in Oncology/Hematology
Elucidating the risk factors and oncogene drivers of acute myeloid leukemia
Daniel Ruben Akiola Sanya, Djamila Onésime · 2025 · Human Cell
Dual Inhibitors of KRASG12D and HSP90 Are Effective against KRASG12D Inhibitor Resistance
Inés Pulido, Laura C. Gunder, Chenghao Ying, Yaya Wang, Yan Dai, Zimo Yang, Alireza Rahnama, Jinhua Li, Yuetong Sun, Chuhe Liu et al. · 2025 · Molecular Cancer Therapeutics
Role of UGP2 as a Biomarker in Colorectal Cancer: Implications for Tumor Progression, Diagnosis, and Prognosis
Lijiao Cui, Caiyuan Yu, Shicai Ye, Yuee Yang, Zhiwei Gu, Vincent Kam Wai Wong, Yu Zhou · 2025 · Current Issues in Molecular Biology
Механизмы резистентности к иммунотерапии при MSI фенотипе
М. Ю. Федянин · 2025 · Malignant tumours
The impact of K-Ras Gly12 mutants on homeostasis and tumorigenesis in the colonic epithelium
Moon Hee Yang, Shikha Sheth, Bing Shui, Isabella N. Grabski, Samuel Seongmin Park, Ana Galán‐Cobo, Rafael Irizarri, John Victor Heymach, Lukas E. Dow, Kevin M. Haigis · 2026 · Oncogene
KRAS and MYC synergistic inhibition: a powerful strategy targeting KRAS-mutant cancers
Man Yan, Kai Liu, Jiayi Xu, Yandi Liu, Liechen Ji, Shiwu Zhang · 2026 · Molecular Cancer
Immune microenvironment evolution across the serrated neoplasia pathway and its relevance to immunotherapy
Chenfei Jin, Haoze Liu, Zejun Wu, Yuyuan Hu, Yipeng Cui, Renkai Guo, Huiyu Li · 2026 · Frontiers in Oncology
KRAS-driven immune exclusion in pancreatic ductal adenocarcinoma: mechanisms and therapeutic reversal
Kenneth Alan Kern · 2026 · The Oncologist
Migration of immune cells in tumors and inflammation: molecular mechanisms and therapeutic targets
Yufeng Lu, D. Shao, Yi Xiao, Yi-Zhou Jiang, Zhi-Ming Shao · 2026 · Signal Transduction and Targeted Therapy
Influence of KRAS mutation subtypes on response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: meta-analysis
Iannish D. Sadien, George Cooper, Veronica Phillips, Heman Joshi, James Wheeler, R Justin Davies · 2026 · BJS Open
A codon-defined translational program promotes RAS-driven cancer progression and drug resistance
Shenghui Xing, Jiahui Li, Ling Ge, Zhennan Shi, Zhihui Liang, Lingnan Ren, Jianhang Huang, Yimin Zheng, Yulin Chao, Jingdong Cheng et al. · 2026 · Vita
[How I treat myelodysplastic syndromes with allogeneic hematopoietic stem cell transplantation].
Erlie Jiang · 2021 · PubMed Central
Clinical Significance and Immune Landscape of Recurrence-Associated Ferroptosis Signature in Early-Stage Lung Adenocarcinoma
Lilan Yi, Ping Cheong Huang, Yinfang Gu, Guowu Wu, Xiaofang Zou, Longhua Guo, Chunling Wen, Junlin Zhu, Dongdong Zhao · 2022 · Frontiers in Oncology
KRAS Wild-Type Pancreatic Cancer: Decoding Genomics, Unlocking Therapeutic Potential
Hiroyuki Kato, Haley Ellis, Nabeel M. Bardeesy · 2023 · Clinical Cancer Research
Viral mimicry evasion: a new role for oncogenic KRAS mutations
Raymond Chen, Aobo He, Daniel Diniz De Carvalho · 2024 · Molecular Oncology
LINC00704 boosts the immunologic escape of colorectal cancer cells by upregulating TLR4 by binding with miR- 203a- 3p
Yalei Jin, Hai Tao, Yuwei Liu, Sha Liu, Xiaoyan Tang · 2025 · European journal of medical research
Tumor Genotype Is Shaping Immunophenotype and Responses to Immune Checkpoint Inhibitors in Solid Tumors
Kathrina L. Marcelo-Lewis, Shhyam Moorthy, Ecaterina Ileana-Dumbrava · 2020 · Journal of Immunotherapy and Precision Oncology
A Comprehensive Guide to the Evaluation of certain interfering SNPs on a lncRNA: miRNA: protein Axis in CRC Diagnosis
Abdullah Radwan · 2023 · ERU Research Journal
A computational network approach to identify predictive biomarkers and therapeutic combinations for anti-PD-1 immunotherapy in cancer
Chia-Chin Wu, Yanru Wang, John Andrew Livingston, Jianhua Zhang, P. Andrew Futreal · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Survival Outcomes of Metastatic Colorectal Cancer Patients in Brunei Darussalam and the Impact of KRAS Mutations
Datul Damit, Ravi Sekhar Patnaik, Liling Chaw, Shir Kiong Lu, Telisinghe Pemasiri Upali, Zen Huat Lu, Kenneth Yuh Yen Kok, Ya Chee Lim · 2020 · Preprints.org
A humanized 4-1BB-targeting agonistic antibody exerts potent antitumor activity in colorectal cancer without systemic toxicity
Liansheng Cheng, Yongfeng Cheng, Wenting Liu, Aolin Shen, Dayan Zhang, Tingjuan Xu, Yin Wu, Min Cheng, Xiaopeng Ma, Feng‐Rong Wang et al. · 2022 · Research Square
IRE-1α is a key switch of pyroptosis and necroptosis in mice by dominating Gasdermin D
Xin Zeng, Qing Zheng, Deyong Li, Yumeng Li, Qing Xu, Xiaohong Liu, Min Zhu, Wen Liu, Lan Li, Yanrong Lu et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Macrophage reprogramming—rather than depletion—is efficacious in a specific subset of colorectal tumor models
Noha-Ehssan Mohamed, Raheleh Amirkhah, Xabier-Cortes Lavaud, Kathryn L. Gilroy, Robin Bartolini, Eoghan J. Mulholland, Abhishek Dinkarnath Garg, Kathryn A.F. Pennel, René Jackstadt, Rachel A. Ridgway et al. · 2023 · Research Square
Data from Facts and Hopes on RAS Inhibitors and Cancer Immunotherapy
Jesse Boumelha, Míriam Molina‐Arcas, Julian Downward · 2023
A machine learning and drug repurposing approach to target ferroptosis in colorectal cancer stratified by sex and KRAS
Hong Yuan Yan, Xinyi Shen, Yisha Yao, Sajid Ali Khan, Shuangge Ma, Caroline Helen Johnson · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Aberrant NOTUM+ Program Induced in LGR5+ Crypt Base Columnar Cells Maintains an Immunosuppressive Niche in Colorectal Cancer
Julian Chua, Parnika Sakthivel, Arshdeep Kaur, Elleine Allapitan, Areeba Maqsood, Oliver F. Bathe, Parham Minoo, Arshad Ayyaz · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Multi omics integration in colorectal cancer: from molecular insights to precision oncology (Preprint)
Zuoliang Liu, Mia Yang Ang, Chin Siang Kue · 2026
Pancreatic Cancer Immuno-oncology in the Era of Precision Medicine
Samarth Hegde · 2020 · Indian Journal of Surgical Oncology
Identification of CXCL8 as an Immune Microenvironment Regulator of Colorectal Cancer: A Bioinformatics Study Based on Cancer Genome Atlas and Gene Expression Omnibus Datasets
Ying Shao, Shuhua Gao, Minrong Cheng, Jinxiu Zheng, Ting Yang, Tie Li, Lijun Yang, Tao Yang · 2020
Interferon Regulatory Factor 2 (IRF2) Inhibits the Invasion and Migration of Renal Clear Cell Carcinoma Cells by Downregulation of Spindle Pole Body Component 24 (SPC24)
Bing Lu, Hongbo Xu, Meng Ding, Chun-yin Yan · 2021 · Journal of Biomaterials and Tissue Engineering
Integrative Analysis of Gene Expression Based on Multi-Omics Databases Identified CXC Chemokines as Immune Prognostic Biomarkers of Rectal Adenocarcinoma
Xiaoshuai Wang, Zhiyang Hu, ZeFeng Du, Dong‐Chun Hong, Haoyang Huang, Yueyin Han, Yingdong Hou, Haoqian Feng, Tianyu Chen, Zhicheng Xue · 2021 · Research Square
Immune checkpoint inhibitors in metastatic colorectal cancer therapy (a review)
П.П. Сорочан, I. А. Hromakova, N. E. Prokhach, I. S. Hromakova · 2022 · Zaporozhye Medical Journal
Spatial multiomics profiling reveals immune features in tumor-adjacent tissues associated with survival of stage I lung squamous cell carcinoma patients
Lisha Ying, Chunliu Zhang, Alexandre Reuben, Yiping Tian, Jiaoyue Jin, Canming Wang, Jing Bai, Jianfei Fang, Tingting Feng, Chenyang Xu et al. · 2022 · Research Square
WITHDRAWN: IRE-1α is a key switch of pyroptosis and necroptosis in mice by dominating Gasdermin D
Xin Zeng, Qing Zheng, Deyong Li, Yumeng Li, Xiaohong Liu, Min Zhu, Wen Liu, Lan Li, Yanrong Lu, Jingqiu Cheng et al. · 2022 · Research Square
Perspective on Immunotherapy of Colon Cancer: Challenges for the Future
Elisa Fontana · 2022 · Cancer immunotherapy
Histone demethylase KDM5D drives sex-specific differences in colorectal cancer
Jiexi Li, Zhengdao Lao, Wenting Liao, James W. Horner, Xueping Xu, Jielin Liu, Yohei Yoshihama, Shan Jiang, Hong Seok Shim, Max Slotnik et al. · 2022 · Leading Edge of Cancer Research Symposium
Mechanistic insights into the interactions between cancer drivers and the tumour immune microenvironment
Hrvoje Mišetić, Mohamed Reda Keddar, Jean‐Pierre Jeannon, Francesca D. Ciccarelli · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Chemokines and Chemokine Receptors in Cancer: An Update
Noha Mousaad Elemam, Azzam A. Maghazachi · 2023 · Springer eBooks
Data from MEK Inhibition Remodels the Immune Landscape of Mutant KRAS Tumors to Overcome Resistance to PARP and Immune Checkpoint Inhibitors
Bin Yang, Xi Li, Yu Fu, Ensong Guo, Youqiong Ye, Fuxia Li, Si Liu, Rourou Xiao, Chen Liu, Funian Lu et al. · 2023
Data from Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma
Wenjing Xuan, Wen‐Hao Hsu, Fatima Khan, Madeline Dunterman, Lizhi Pang, Derek Alan Wainwright, Atique U. Ahmed, Amy B. Heimberger, Maciej S. Lesniak, Peiwen Chen · 2023
Supplementary Figure from Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma
Wenjing Xuan, Wen‐Hao Hsu, Fatima Khan, Madeline Dunterman, Lizhi Pang, Derek Alan Wainwright, Atique U. Ahmed, Amy B. Heimberger, Maciej S. Lesniak, Peiwen Chen · 2023
Data from CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies
Dongrui Wang, Briana C. Prager, Ryan C. Gimple, Brenda Aguilar, Darya Alizadeh, Hongzhen Tang, Deguan Lv, Renate Starr, Alfonso Brito, Qiulian Wu et al. · 2023
Data from Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma
Wenjing Xuan, Wen‐Hao Hsu, Fatima Khan, Madeline Dunterman, Lizhi Pang, Derek Alan Wainwright, Atique U. Ahmed, Amy B. Heimberger, Maciej S. Lesniak, Peiwen Chen · 2023
Supplementary Table 2 from CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies
Dongrui Wang, Briana C. Prager, Ryan C. Gimple, Brenda Aguilar, Darya Alizadeh, Hongzhen Tang, Deguan Lv, Renate Starr, Alfonso Brito, Qiulian Wu et al. · 2023
Recent advancements in tumour microenvironment landscaping for target selection and response prediction in immune checkpoint therapies achieved through spatial protein multiplexing analysis
Madhavi Dipak Andhari, Asier Antoranz, Frederik De Smet, Francesca Maria Bosisio · 2023 · International review of cytology
The Characteristics Of Tumor Microenvironment In Colorectal Cancer With Different Msi Status And Current Therapeutic Strategies
Qingzhe Wang, Min Yu, Shuang Zhang · 2023 · SSRN Electronic Journal
Data from Facts and Hopes on RAS Inhibitors and Cancer Immunotherapy
Jesse Boumelha, Míriam Molina‐Arcas, Julian Downward · 2023
Identification of the transcriptomic alterations of resistance to immune checkpoint inhibitors in melanoma
Qiyao Mak · 2024 · Theoretical and Natural Science
Determining the link between psoriasis and Crohn's disease using bioinformatics and systems biology approaches
Shihao Xu, Ya Li, Xin Yang, Chaozheng Xie, Kuan He, Zhengqiang Wei · 2024 · Research Square
Additional file 1 of Identification of a novel m6A-related lncRNAs signature and immunotherapeutic drug sensitivity in pancreatic adenocarcinoma
Xiaqing Li, Shi-Qi Yin, Chen, Lin, Aziguli Tulamaiti, Xiao, Shu-Yu, Xueli Zhang, Lei Shi, Xiao-Cao Miao, Yang Yan, Xin Xing · 2024 · Figshare
Cell of origin alters myeloid-mediated immunosuppression in lung adenocarcinoma
Minxiao Yang, Noah Shulkin, Edgar Gonzalez, Jonathan Castillo, Chunli Yan, Keqiang Zhang, Leonidas D. Arvanitis, Zea Borok, William D. Wallace, Dan J. Raz et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
WITHDRAWN: IRE-1α is a key switch of pyroptosis and necroptosis in mice by dominating Gasdermin D
Xin Zeng, Qing Zheng, Deyong Li, Yumeng Li, Xiaohong Liu, Min Zhu, Wen Liu, Lan Li, Yanrong Lu, Jingqiu Cheng et al. · 2024 · Research Square
Exploration of the Clinical Value of CXCL3 in Colon Adenocarcinoma Based on Bioinformatics
俊安陶 · 2024 · Advances in Clinical Medicine
Immune-oncology potential of KRAS inhibitors
Míriam Molina‐Arcas, Jesse Boumelha, Julian Downward · 2024 · Elsevier eBooks
RASopathy Genes: Germline Risk and Somatic Cancers
Gina M. Ney, Christian Peter Kratz, Douglas R. Stewart · 2024 · Springer eBooks
Interpretable deep learning quantifies the impact of genomic variations on CD8+ T cell infiltration
Yi He, Liwen Xu, Xiang Wang, Shaoliang Peng · 2024 · IEEE International Conference on Bioinformatics and Biomedicine (BIBM)
The accumulation of harmful genes within the ROH hotspot regions of the Tibetan sheep genome does not lead to genetic load
Lixia Sun, Chao Yuan, T. Guo, Yaqin Bai, Zeng-Kui Lu, Jian-Bin Liu · 2025 · BMC Genomics
Precision treatment for human epidermal growth factor receptor 2-amplified advanced rectal cancer: A case report
Xiao Xia, Qingwen Wang, Zhengyang Zhou, Lei-Sheng Wang, Pei Yu Huang · 2025 · World Journal of Gastrointestinal Oncology
Regulation mechanism of chemokine CXCL3 in nasopharyngeal carcinoma
Jiafeng Zhuang, Jiecheng Yan, Shumin Zhai, Peixin Lin, Danxian Jiang, Weiyuan Huang, Jing Huang · 2025 · Pathology - Research and Practice
Inflammatory cell death and leukemia treatment
Saqib Ishaq, Sajida Afzal, Shabir Ahmad Usmani, Ibtasam Wajid, Abdul Aziz, Raheel Tahir, Ajaz Ahmad, Amin Ullah · 2025 · Critical Reviews in Oncology/Hematology
Chemokines and Chemokine Receptors in Cancer: An Update
Noha Mousaad Elemam, Azzam A. Maghazachi · 2025 · Springer eBooks
Leveraging death of drug-sensitive cancer cells to promote immune-mediated bystander killing of subclones of drug-resistant tumour cells
Mona Tomaschko, KangBo Ng, Christopher Moore, Claire E. Pillsbury, Sareena Rana, James Campbell, Saptaparna Mukherjee, Ania Mikolajczak, Panayiotis Anastasiou, Andrea de Castro et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Additional file 1 of HOXA7 promotes the metastasis of KRAS mutant colorectal cancer by regulating myeloid-derived suppressor cells
Yunzhi Dang, Yu, Jiao, Zhao, Shuhong, Cao, Ximing, Wang, Qing · 2022 · Figshare
Additional file 1 of Common and mutation specific phenotypes of KRAS and BRAF mutations in colorectal cancer cells revealed by integrative -omics analysis
Snehangshu Kundu, Muhammad Akhtar Ali, Niklas Handin, Conway, Louis P., Verónica Rendo, Per Artursson, He, Liqun, Daniel Globisch, Tobias Sjöblom · 2021 · Figshare
Additional file 1 of Unraveling epigenomic signatures and effectiveness of electroconvulsive therapy in treatment-resistant depression patients: a prospective longitudinal study
Carvalho Silva, Rosana, Martini, Paolo, Christa Hohoff, Stefania Mattevi, Marco Bortolomasi, Maria Abate, Valentina Menesello, Massimo Gennarelli, Baune, Bernhard T., Alessandra Minelli · 2024 · Figshare
Additional file 1 of KRASG12C inhibition using MRTX1257: a novel radio-sensitizing partner
Laurent, Pierre-Antoine, Marina Milić, Clément Quevrin, Lydia Meziani, Winchygn Liu, Daphné Morel, Nicolas Signolle, Céline Clémenson, Antonin Lévy, Michele Mondini et al. · 2023 · Figshare
Additional file 1 of A humanized 4-1BB-targeting agonistic antibody exerts potent antitumor activity in colorectal cancer without systemic toxicity
Cheng, Lian-sheng, Cheng, Yong-feng, Liu, Wen-ting, Shen, Aolin, Zhang, Dayan, Xu, Tingjuan, Yin, Wu, Cheng, Min, Ma, Xiaopeng, Wang, Fengrong et al. · 2022 · Figshare
Additional file 1 of Aryl hydrocarbon receptor nuclear translocator limits the recruitment and function of regulatory neutrophils against colorectal cancer by regulating the gut microbiota
Bi, Yujing, Qiuli Yang, Zhengchao Li, Wang, Yuexin, Wang, Yufei, Anna Jia, Pan, Zhiyuan, Ruifu Yang, Liu, Guangwei · 2023 · Figshare
Additional file 2 of Aryl hydrocarbon receptor nuclear translocator limits the recruitment and function of regulatory neutrophils against colorectal cancer by regulating the gut microbiota
Bi, Yujing, Qiuli Yang, Zhengchao Li, Wang, Yuexin, Wang, Yufei, Anna Jia, Pan, Zhiyuan, Ruifu Yang, Liu, Guangwei · 2023 · Figshare
Additional file 1 of Sintilimab plus bevacizumab and CapeOx (BBCAPX) on first-line treatment in patients with RAS mutant, microsatellite stable, metastatic colorectal cancer: study protocol of a randomized, open-label, multicentric study
Xuefeng Fang, Zhong, Chenhan, Shanshan Weng, 胡涵光, Wang, Jian, Qian Xiao, Jianwei Wang, Lifeng Sun, Dong Xu, Liao, Xiujun et al. · 2023 · Figshare
Genotype-phenotype mapping identifies fetal-like CD55 + immunoregulatory cancer cells as mediators of immune escape in colorectal cancer
Manuel Mastel, Aitana Guiseris Martinez, Gabriele Diamante, Jasmin Meier, Luzi Schuchmann, Nikolaos Georgakopoulos, Ioannis Chiotakakos, Laura K. Steffens, Carolin Artmann, Diego Benítez-Riquelme et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
Drug resistance-driven cytokine alterations in the immunosuppressive microenvironment of colorectal cancer
Yingying Shao, Zewen Zhang, Yu Wang, Chunze Zhang, Erwei Liu, Haiyang Yu · 2026 · Targetome
Precision Targeting Of Ferroptosis In Colorectal Cancer: Sex- and KRAS Mutation-Driven Metabolic Vulnerabilities and Drug Repurposing
Hong Yan, Xinyi Shen, Chen Chen, Yisha Yao, Jieqing Feng, John F Quackenbush, Sajid A. Khan, Shuangge Ma, Caroline Helen Johnson · 2025 · SSRN Electronic Journal
Bridging cancer cell-intrinsic driver genes and -extrinsic cell-cell communication with Driver2Comm
Run-Zhi Xie, Jun-Ping Li, Yuxuan Hu, Lin Gao · 2026 · PLoS Comput. Biol.
Genetic Alterations Involved in Immune Escape Mechanisms of Circulating Tumour Cells in Colorectal Carcinogenesis
Sharmin Aktar, Matthew Masoudi, Dilpreet Moti, Vinod Gopalan, Farhadul Islam, Alfred King-yin Lam · 2026 · Cancer Medicine
RUNX1 restrains STAT1-GITRL signaling to shape an immunosuppressive CRC microenvironment
Wenting He, Lisheng Zheng, Weiye Huang, Keren Li, Yitian Chen, Rui Zeng, Z Lin, Yangwei Xu, Shengfeng Hu, Qingling Zhang · 2026 · Cell Death Discovery
O-GlcNAcylation of UGDH: emerging insights into immunometabolic regulation and therapeutic implications
Qiang Wu, Ting Lei, Shujing Wang · 2026 · Cell Death Discovery
Efficacy and synergy of low-dose radiotherapy combined with anti-PD-L1 based immunotherapy
Pierre-Antoine Laurent · 2023
DiffDriver Detects Context-Associated Selection of Cancer Driver Genes
Jie Zhou, Qirui Zhang, Li Song, Xin He, Siming Zhao · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
Advances and challenges in immunotherapy for advanced esophageal squamous cell carcinoma
Ying Wang, Hui Li, Peiyan Zhao, Zhiming Li, S. Zhang · 2026 · Frontiers in Immunology
TGFβ-SMAD2/3 signaling inhibits IRF2 to drive metastasis in KRAS-mutant colorectal cancer
Feng Shu, Tao Zhang, Xu Chen, Guohao Lu, Shi Guo, Yaxin Zhang, Chengmei Huang, Wenting Liao, Yanru Wang · 2026 · Cancer Letters
Combining the KRASG12C inhibitor adagrasib with anti-PD-1 immunotherapy improves overall survival and prevents recurrence in preclinical models of brain metastasis
Consuelo Torrini, Naema Nayyar, Gregory R. Wojtkiewicz, Anita Giobbie‐Hurder, Magali A. de Sauvage, Christian Migliarese, Elizabeth Summers, Nazanin Ijad, Erika Yamazawa, Britney S. Zhang et al. · 2026 · Neuro-Oncology Advances
Natural Products Targeting the Tumor Microenvironment: A Comprehensive Overview of Colorectal Cancer Therapeutics
Yuquan Tao, Tianyi Zhang, Dan Dong, Ye Zhang, Qinchang Zhang, 耿学辰, Dongdong Sun, Liu Li, Min Li, Yang Sun et al. · 2026 · Cancer Bioscience
Ammonia metabolic reprogramming in the tumor microenvironment: emergence of an immunosuppressive niche
Zihao Ye, Hao Wu, Zhanhao Li, Ruizhe Ye, 饶应良, Bin Liu, Baoshan Gao · 2026 · Frontiers in Cell and Developmental Biology
CD69 blockade restores the bone marrow niche and delays leukemogenesis in a mouse model of Nras G12D -driven chronic myelomonocytic leukemia
Yingying Li, Xu Jiang, Yinfeng Gu, Xianfeng Zha, Jie Wu, Xiuli Wu, Chunli Qi, Shaohua Chen, Yangqiu Li, Zhenyi Jin et al. · 2026 · Cancer Biology & Therapy
Continuous multi-omics pathway enrichment analysis resolves hidden functional heterogeneity
Sareh AmeriFar, Andreas Kopf, Steffen Sass, Zahra Moslehi, Dennis Hecker, Julius Christoph Enssle, Marcel H. Schulz, Thomas Oellerich, Fabian Joachim Theis, Florian Buettner · 2026 · Briefings in Bioinformatics
Anti-TIGIT therapies in digestive cancers: from immune evasion to precision immunotherapy
M Matar, Céline Yaghi, Gilles Prince, Houssam El Masri, Hampig Raphaël Kourié · 2026 · Immunotherapy
Navigating the landscape of CD8+ T cell tumor infiltration: Barriers, mechanisms, and therapeutic opportunities
Zhengkui Zhang, Yuanzhuo Gu, Shilei Qiao, Linpeng Sang, Long Zhang, Fangfang Zhou · 2026 · Cell Press Blue
Systemic immune remodeling following curative (R0) resection of colorectal liver metastases
Shuo Ren, Migmar Tsamchoe, Stephanie K. Petrillo, Oran Zlotnik, Jessica Bloom, Anastasia Tsatoumas, Vered Domankevich, Anthoula Lazaris, Peter P. Metrakos · 2026 · Frontiers in Immunology
Oncogenic KRAS Promotes Extracellular DNA Clearance to Drive Immunosuppression in Colorectal Cancer
Kathleen M. McAndrews · 2026 · Cancer Research